Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $6.85 million. The enterprise value is -$11.20 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 10.59 million shares outstanding. The number of shares has increased by 1,648.49% in one year.
| Current Share Class | 10.59M |
| Shares Outstanding | 10.59M |
| Shares Change (YoY) | +1,648.49% |
| Shares Change (QoQ) | +229.76% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 1.29% |
| Float | 10.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61
| Current Ratio | 5.61 |
| Quick Ratio | 5.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.68 |
Financial Efficiency
Return on equity (ROE) is -160.84% and return on invested capital (ROIC) is -96.41%.
| Return on Equity (ROE) | -160.84% |
| Return on Assets (ROA) | -76.19% |
| Return on Invested Capital (ROIC) | -96.41% |
| Return on Capital Employed (ROCE) | -94.62% |
| Weighted Average Cost of Capital (WACC) | -1.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.36% in the last 52 weeks. The beta is -0.96, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.96 |
| 52-Week Price Change | -95.36% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 4.40 |
| Relative Strength Index (RSI) | 21.33 |
| Average Volume (20 Days) | 254,457 |
Short Selling Information
The latest short interest is 1.03 million, so 9.77% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 9.77% |
| Short % of Float | 9.80% |
| Short Ratio (days to cover) | 0.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.04M |
| Pretax Income | -16.73M |
| Net Income | -16.73M |
| EBITDA | n/a |
| EBIT | -16.04M |
| Earnings Per Share (EPS) | -$6.45 |
Full Income StatementBalance Sheet
The company has $18.05 million in cash and n/a in debt, with a net cash position of $18.05 million or $1.70 per share.
| Cash & Cash Equivalents | 18.05M |
| Total Debt | n/a |
| Net Cash | 18.05M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 16.93M |
| Book Value Per Share | 1.87 |
| Working Capital | 15.45M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -14.29M |
| FCF Per Share | -$1.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
